Immediate Impact
66 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Macrophage plasticity: signaling pathways, tissue repair, and regeneration
2024 Standout
Works of Anna Illiano being referenced
Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways
2017
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study
2004
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Anna Illiano | 242 | 160 | 42 | 164 | 53 | 736 | |
| Hongjian Chen | 325 | 122 | 37 | 151 | 36 | 796 | |
| Jyoti Sharma | 205 | 97 | 44 | 50 | 65 | 830 | |
| Xinyun Zhang | 240 | 59 | 33 | 99 | 52 | 683 | |
| Todd Hsu | 255 | 70 | 27 | 78 | 43 | 702 | |
| Mehdi Barati | 175 | 52 | 112 | 87 | 53 | 636 | |
| Jinxin Li | 198 | 43 | 55 | 71 | 65 | 698 | |
| Xiaohui Liang | 404 | 100 | 51 | 88 | 47 | 785 | |
| Yi‐Han Chiu | 339 | 93 | 91 | 73 | 44 | 807 | |
| Elaheh Amini | 259 | 90 | 46 | 51 | 67 | 844 | |
| Hadi Ghaffari | 191 | 54 | 47 | 73 | 34 | 817 |
All Works
Login with ORCID to disown or claim papers
Loading papers...